Skip to main content
Figure 1 | BMC Pharmacology

Figure 1

From: Weight loss dynamics during combined fluoxetine and olanzapine treatment

Figure 1

Tissue necrosis during chronic fluoxetine (fluox) and olanzapine (olanz) treatment. This figure depicts equally excised peritoneal cavities of males injected IP with either a vehicle-solution (cyclodextrin) or the above drug combination pattern for 18 consecutive days. Note the extent of tissue damage (~1 cm wide) at the site of drug administration. Focal necrosis was evident in drug-treated rats irrespective of olanzapine dosing.

Back to article page